research article

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database

Authors
Publication date
1 January 2024
Publisher
Ferrata Storti Foundation
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      IRIS UniSR (’Università Vita-Salute San Raffaele)

      redirect
      oaioai:iris.unisr.it:20.500.11768...
      Last time updated on 28/01/2026